Cases & Deals

  • Home
  • Practices
  • Anteris Technologies establishes $250 million at-the-market equity program

Share

Anteris Technologies establishes $250 million at-the-market equity program

May 2026

Client(s) Anteris Technologies Global Corp.

Jones Day represented Anteris Technologies Global Corp. (NASDAQ: AVR; ASX:AVR) ("Anteris") in connection with the establishment of an at-the-market equity program for the sale of up to $250 million of its shares of Common Stock. Issuances and sales under the program may be made from time to time through the sales agent.

Anteris is a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function. Founded in Australia, with a significant presence in Minneapolis, USA, Anteris is a science-driven company with an experienced team of multidisciplinary professionals delivering restorative solutions to structural heart disease patients.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.